Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1998 1
2005 1
2006 1
2007 4
2008 4
2009 3
2010 13
2011 4
2012 9
2013 4
2014 5
2015 2
2016 3
2017 1
2018 2
2019 1
2020 5
2021 1
2022 5
2023 4
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

66 results

Results by year

Filters applied: . Clear all
Page 1
Hyperlipidemic myeloma.
Gozzetti A, Defina M, Bocchia M, Lauria F. Gozzetti A, et al. Among authors: defina m. Ann Hematol. 2010 Sep;89(9):939-40. doi: 10.1007/s00277-010-0905-5. Epub 2010 Feb 2. Ann Hematol. 2010. PMID: 20127090 No abstract available.
Peptide vaccines for hematological malignancies: a missed promise?
Bocchia M, Defina M, Aprile L, Sicuranza A. Bocchia M, et al. Among authors: defina m. Int J Hematol. 2014 Feb;99(2):107-16. doi: 10.1007/s12185-013-1497-3. Epub 2014 Jan 8. Int J Hematol. 2014. PMID: 24399190 Free article. Review.
Extramedullary myeloma relapses.
Gozzetti A, Papini G, Defina M, Bocchia M. Gozzetti A, et al. Among authors: defina m. Ann Hematol. 2012 Sep;91(9):1511-2. doi: 10.1007/s00277-012-1432-3. Epub 2012 Feb 25. Ann Hematol. 2012. PMID: 22362123 No abstract available.
Blinatumomab and Inotuzumab Ozogamicin Sequential Use for the Treatment of Relapsed/Refractory Acute Lymphoblastic Leukemia: A Real-Life Campus All Study.
Fracchiolla NS, Sciumè M, Papayannidis C, Vitale A, Chiaretti S, Annunziata M, Giglio F, Salutari P, Forghieri F, Lazzarotto D, Lunghi M, Imovilli A, Scappini B, Bonifacio M, Dargenio M, Gurrieri C, Todisco E, Defina M, Del Principe MI, Zappasodi P, Cerrano M, Santoro L, Tagliaferri E, Barozzi E, De Roberto P, Canzi M, Buzzatti E, Sartor C, Passamonti F, Foà R, Curti A. Fracchiolla NS, et al. Among authors: defina m. Cancers (Basel). 2023 Sep 19;15(18):4623. doi: 10.3390/cancers15184623. Cancers (Basel). 2023. PMID: 37760592 Free PMC article.
FLT3 Inhibitors in the Management of Acute Myeloid Leukemia.
Zappone E, Defina M, Aprile L, Bartalucci G, Gozzetti A, Bocchia M. Zappone E, et al. Among authors: defina m. Anticancer Agents Med Chem. 2017;17(8):1028-1032. doi: 10.2174/1871520616666161010162737. Anticancer Agents Med Chem. 2017. PMID: 27748173 Review.
Multicenter retrospective analysis of clinical outcome of adult patients with mixed-phenotype acute leukemia treated with acute myeloid leukemia-like or acute lymphoblastic leukemia-like chemotherapy and impact of allogeneic stem cell transplantation: a Campus ALL study.
Lazzarotto D, Tanasi I, Vitale A, Piccini M, Dargenio M, Giglio F, Forghieri F, Fracchiolla N, Cerrano M, Todisco E, Papayannidis C, Leoncin M, Defina M, Guolo F, Pasciolla C, Delia M, Chiusolo P, Mulè A, Candoni A, Bonifacio M, Pizzolo G, Foà R. Lazzarotto D, et al. Among authors: defina m. Ann Hematol. 2023 May;102(5):1099-1109. doi: 10.1007/s00277-023-05162-0. Epub 2023 Mar 24. Ann Hematol. 2023. PMID: 36959485
Plasmacytoma of the skull.
Gozzetti A, Cerase A, Defina M, Bocchia M. Gozzetti A, et al. Among authors: defina m. Eur J Haematol. 2012 Apr;88(4):369. doi: 10.1111/j.1600-0609.2011.01714.x. Epub 2011 Nov 15. Eur J Haematol. 2012. PMID: 22082085 No abstract available.
Long-Term Safety of Rapid Daratumumab Infusions in Multiple Myeloma Patients.
Gozzetti A, Bacchiarri F, Sammartano V, Defina M, Sicuranza A, Mecacci B, Zappone E, Cencini E, Fabbri A, Raspadori D, Bocchia M. Gozzetti A, et al. Among authors: defina m. Front Oncol. 2020 Dec 21;10:570187. doi: 10.3389/fonc.2020.570187. eCollection 2020. Front Oncol. 2020. PMID: 33415072 Free PMC article.
Daratumumab with or without chemotherapy in relapsed and refractory acute lymphoblastic leukemia. A retrospective observational Campus ALL study.
Cerrano M, Bonifacio M, Olivi M, Curti A, Malagola M, Dargenio M, Scattolin AM, Papayannidis C, Forghieri F, Gurrieri C, Tanasi I, Zappasodi P, La Starza R, Fracchiolla NS, Chiusolo P, Giaccone L, Del Principe MI, Giglio F, Defina M, Favre C, Rizzari C, Castella B, Pizzolo G, Ferrara F, Chiaretti S, Foà R. Cerrano M, et al. Among authors: defina m. Haematologica. 2022 Apr 1;107(4):996-999. doi: 10.3324/haematol.2021.279851. Haematologica. 2022. PMID: 35021604 Free PMC article. No abstract available.
COVID-19 infection in acute lymphoblastic leukemia over 15 months of the pandemic. A Campus ALL report.
Chiaretti S, Bonifacio M, Agrippino R, Giglio F, Annunziata M, Curti A, Principe MID, Salutari P, Sciumè M, Delia M, Armenio M, Mancini V, Mulè A, Grimaldi F, Rege-Cambrin G, Santoro L, Lussana F, Chiusolo P, Pasciolla C, Scattolin AM, Cerrano M, Ciccone M, Defina M, Forghieri F, Mazzone C, Piccini M, Ferrara F, Pizzolo G, Foà R. Chiaretti S, et al. Among authors: defina m. Haematologica. 2022 Aug 1;107(8):1955-1959. doi: 10.3324/haematol.2021.280289. Haematologica. 2022. PMID: 35443561 Free PMC article. No abstract available.
66 results